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Communication
It is hard to overestimate the importance of communication in
our modem society - and the significant communication
changes that we have all seen in the form of e-mail, web sites,
teleconferences and the now essential cellular phones. There
is the art and the science of communication, the personal and
the impersonal. Man is a social animal and usually needs to
communicate in one form or another. Because of the personal
nature of healthcare, we are frequently dealing with people
(patients and families}, in one capacity or another, often
discussing topics of personal risk. Better techniques of
communication would make us more effective and make our
jobs more satisfying.
Patients- The Hospital Association of Pennsylvania is
sponsoring workshops aimed at helping clinicians
communicate better with patients. I will be attending the first of
these later this month and plan to share the key points with
you. Patients who feel connected to their physicians are more
likely to ask questions, participate in decisions and have better
health outcomes. Better communication with patients might
also avoid unrealistic expectations of healthcare interventions
and avoid surprises.
Physicians - Better communication between and among
healthcare providers might improve patient care and
coordinate both our hospital and outpatient care. It could also
serve as a source of mutual support for caregivers who could
understand each othe(s problems and concerns. I am all
about communication since it is essential to team building and today's healthcare is a team effort. Each member of the
team is important in his/her own way and must view his/her
task as essential to the success of the team. Winning teams
support and value one another - true in basketball and
healthcare.

We must remember that LVHHN's greatest asset is its
workforce, and retention strategies need communication with
all involved.
(Continued on Page 2)
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When you love something, set it free.
If it comes back to you, ifs yours.
If it doesn't, it never was.
- Folk Wisdom

What ever happened to those goals for the Medical Staff
leadership?
Respect: We said we would value and respect the individual
contribution of every member of the medical staff and assume
positive intent. We have done that in a variety of contexts and
will continue to do so.
Communicate: We have visited Division meetings and reached
numerous staff members in person or by phone for their input
on the LVH medical staff. We have used e-mail plus the
written monthly Medical Staff Progress Notes. I am working
to improve our performance in this vital area.
Advise: We continue to identify and analyze trends and
developments in the world of healthcare and relate them to the
ifiedical staff for their awareness.
~epresent:

Medical staff leadership understands that our
primary goal is to represent the diverse interests of the medical
staff, as best we can, and to act on your behalf. While most
issues are straight forward, some are complex and may
require consultation with various medical staff members.

A banker is a fellow who lends you his umbrella when the sun
is shining, and wants it back the minute it begins to rain.
-Mark Twain

Autonomy is an important aspect of our function as a medical
staff and requires motivation and interest in traditional medical
staff duties. The present structure of a medical staff
organization with departments, divisions and committees
allows individual input and quality improvement assessment. It
works as long as the medical staff stays involved and focused.
Professionalism - a professional is always the patient's
advocate. He/she assures that decisions are made by those
who cleariy understand the priority of patient care issues and
quality of care. We need to participate in governance issues of
healthcare delivery systems and managed care forums. As
respected voices in our communities, we need to influence and
mold the political process at various levels. Medical staff
leadership understands your competing time pressures and
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concerns: the unfair Medicare physician payment reduction,
the impact of HIPAA on your office, bioterrorism, malpractice,
EMTALA, ER call schedule, hospital staff shortages,
institutional competition. And after all this, I want you to
become involved in the political process and call your state
representative? Are all these items important? Of course, just
like your pension/profit-sharing plan and your office staffing
problems. Some days, life can be stressful and it feels like we
are on a treadmill- Level 9. On the other hand, we cannot
forget the prime reason we are in healthcare. We have a
fiduciary responsibility to patients to protect their interests. We
are professionals.

"There is nothing more difficult to take in hand, more perilous
to conduct, or more uncertain in its success than to take the
lead in the introduction of a new order of things. •
- Niccolo Machiavelli

CAPOE Rollout Plans - Increasing numbers of
medical staff members have been trained and are
now using the computer assisted physician order
entry on 68 and the TTU. The feedback has been
positive and the Information Services personnel have
done everything possible to make it an easy
transition. They usually have a representative
stationed on the unit during the day. Your Troika
membership has tried it and it has worked well for us.
We would like to thank Dr. Don Levick, Information
Services, and the CAPOE Design Committee for their
considerable work in designing this system - which is
a fluid and dynamic program - continually evolving
and improving. Recently, LVHHN was recognized by
the Leapfrog Group as a Pennsylvania leader in using
CAPOE to reduce medical errors and improve patient
safety. As noted below, they are active...
A CONSORTIUM OF LARGE EMPLOYERS AND HEALTH
CARE PURCHASERS PLANS TO RATE HOSPITALS BY
THEIR ADHERENCE TO COMPUTERIZED PHYSICIANORDER ENTRY SYSTEMS.
The Leapfrog Group sees the system as one of three practices
that can reduce preventable mistakes in hospitals; the other
two are sticking to guidelines for treatment of high-risk
conditions and proper staffing levels in intensive care units,
reported the Wall Street Journal. Doctors would use such a
system by inputting every prescription and order for drugs, lab
tests and procedures, while the computer program then
responds with alerts for drug allergies and interactions and
information on new therapies, the Journal noted. Wall Street
Journal, March 15, 2002
(Continued on Page 3)
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•!• Dijon Vu -the same mustard as before

•!• Shotgun wedding - a case of wife or death
•!• A gossip is someone with a great sense of rumor.

Edward M. Mullin, Jr., MD
Medical Staff President

News from CAPOE Central
As many physicians are aware, CAPOE went live on 6B at
Cedar Crest &1-78 on February 20, 2002. The process has
gone quite well- the Internal Medicine residents have been
very compliant with entering orders on-line, and several
residents have entered ALL their orders on-line. The Internal
Medicine and Neurology attendings have been very
cooperative, with most of them entering orders on-line and
showing great patience as the residents learn the system. The
support on 6B and TTU by the CAPOE team has been a
critical part of the success. I would like to congratulate
everyone involved for their hard work and commitment to the
project.
Several physicians have asked why the Vital Signs (VS) and
the Medication Administration Record (MAR) are now available
only on-line, and are not being printed. All of the decisions in
the CAPOE project are being driven by the goal of improving
quality of care and improving patient safety. By charting VS
and MAR on-line, we are able to ensure more accurate and
timely data. The on-line record will always reflect the most
recent data available for a patient. Printing the patient data will
create confusion regarding which is the most up-to-date
.
record, and will create duplicative work for people. Recording
medications on-line will contribute to decreasing errors in
transcription and administration. This process will also
integrate into potential future technologies that will further
reduce or eliminate medication errors. By having this patient
data on-line, it is available remotely - from any unit, the
Medical Staff lounge, the physician's office, or from home. We
can build decision support tools that integrate with the data alerting physicians or nurses about potential problems,
triggering of events (CBC and cultures when fever is recorded
on-line). Using the "Viewer,• physicians can create custom
views and graphs that highlight specific parameters. We have
set up a view for the Infectious Disease physicians that
automatically graphs temperature vs. WBC counts. We have a
view that shows and graphs coagulation labs against anti-

coagulant medication doses. Having the data on-line will also
allow us to capture the data and help analyze outcomes and
medical quality.
We believe, as has been shown in the literature, that the
benefits of computer physician order entry and on-line
documentation of medication administration outweigh the work
of learning the change in process.
I appreciate that this system requires access to a computer
and that log-in time has been an issue. We are addressing
this in several ways, and continue to evaluate new options.
Many groups have been offered handheld computers
(PenCentras). By carrying the computer around, the number
of log-ins is greatly reduced or eliminated. Although carrying a
device is a change in work habits, we believe the benefits are
worth considering. There are four laptops on carts located
throughout each CAPOE unit. These are available for use by
the medical staff. We have evaluated these units, and have
found login time to be consistently less than thirty seconds.
Screen clarity is excellent, and response time is very fast. The
existing workstations are also available for use, and are being
monitored to keep them running as fast as possible.
We have deliberately paced the rollout of CAPOE units to
allow the medical staff time to acclimate to the new system and
for the CAPOE team to respond to user requests and
enhancements.
Please contact me with any questions or if you would like more
information.
Don Levick, MD, MBA
(484) 884-4593 (office) or (610) 402-5100 7481 (pager)

? ? ? Mystery Medical Staff Member ? ? ?
? Born in Wilmington, Del.
? Earned Bachelor of Arts degree from the
University of Delaware
? Graduated from the University of Pennsylvania
School of Medicine
? Completed rotating internship at York Hospital
? Completed three-year residency at the .
University of Pennsylvania Hospital
? Joined the Medical Staff in 1975
? Wife's name is Patricia
? Two children and one grandchild
? Drives a Silver BMW
? Enjoys gardening, golfing, fishing, sailing and

playing bridge
Give up? Please see Page 12 for the answer.
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Spotlight on ...
Larry R.. Glazerman, MD

,~

Born 1n Ph1ladelph1a, Pa., Dr.
Glazerman completed his
undergraduate education at
Muhlenberg College in Allentown, Pa., where he earned a
Bachelor of Science degree. He received his medical degree
from Jefferson Medical College of Thomas Jefferson University
in Philadelphia, Pa. He completed a four-year Obstetrics and
Gynecology residency at Lehigh Valley Hospital (formerly
known as the Allentown Affiliated Hospitals). Dr. Glazerman is
certified and recertified by the American Board of Obstetrics
and Gynecology. He is also certified by the Accreditation ·
Council for Gynecologic Endoscopy.
Dr. Glazerman joined the hospital's Medical Staff in 1980, and
is a member of the Department of Obstetrics and Gynecology,
Division of Primary Obstetrics and Gynecology. He is a
Clinical Assistant Professor of Obstetrics & Gynecology at
Pennsylvania State University College of Medicine. Dr.
Glazerman is in private practice with OB-GYN at Trexlertown,
PC. Among his interests are computers in medicine and
laparoscopic surgery. In fact, he performed the first
laparoscopic hysterectomy in the Lehigh Valley.
On a more personal note, Dr. Glazerman and his wife, Joan,
have three children. In his spare time, Dr. Glazerman enjoys
golf, skiing, and computers. Though a Philadelphia native, he
now considers the Lehigh Valley as home, and only returns to
Philadelphia for cheesesteaks, soft pretzels, and sporting events.
In conclusion, Dr. Glazerman has the following comments to
share with his colleagues on the Medical Staff:
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Dental Consultations
The Department of Dental Medicine would like to remind the
Medical Staff that the six dental residents are available to
perform in-patient dental consultations at all three hospital
campuses. Consults at 17th & Chew or Cedar Crest & 1-78
must be forwarded through Lastword to the Dental Clinic at
17th & Chew. Consults at LVH-Muhlenberg must be forwarded
through Lastword to the Dental Center at LVH-Muhlenberg. It
is also recommended that a phone call be placed to the
appropriate dental clinic in conjunction with the request via
Lastword. Please remember to include the Reason for
Consultation. For example, appropriate reasons include the
following:
evaluation of intraoral lesions, swelling and/or infection; trauma
to teeth and/or jaws, pre-operative evaluation prior to heart
valve replacement, organ transplants, or radiation/oncology
treatment.
Please do not request consultations for elective treatment such
as cleaning of teeth, fillings, denture relines, or orthodontic
treatment. Patients requiring these treatments should be
referred for dental care after discharge.
If you have any questions, please contact one of the Dental
Residency Program Directors: Charles J. lncalcaterra, DMD,
17111 & Chew- (610) 402-2245, or Russ S. Bergman, DMD,
LVH-Muhlenberg- (484) 884~2315.

In celebration of Nurses Week,
members of the Medical Staff
are cordially invited to attend the

2002 Nursing Gala
•

Change is inevitable. Those who embrace change
and look for opportunity in it will thrive. (Everyone
should read "Who Moved My Cheese• by Spencer
Johnson, MD.)

•

What's true today won't be true tomorrow. This is as
true in medicine as in other parts of our lives.

Thursday, May 2, 2002
Holiday Inn Conference Center
Fogelsville, Pennsylvania

•

In the turbulent times we're in, it's sometimes hard to
sort out the players, and who's on which side.
Remember that we're on the side of the patients!

5:30 p.m. - Reception
7 p.m. -Awards Presentation

•

Remember that we're our patients' partners. Our job
is to inform and advise them, not to be the ultimate
authority on decisions that affect their health.

RSVP by Friday, April26, 2002
to Kim Hitchings at (610) 402-1704

honoring our staff
and the Friends of Nursing
award winners and donors.
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Ethics Corner
by Glenn A. Mackin, MD, Chairperson, Ethics Committee
Before embarking on my six-month series of commentaries on
the AMA's important new Ethical Guideline E-8.061, "Gifts to
Physicians from Industry", a few words of thanks are in order.
To my medical staff colleagues, it is a privilege for me to
practice medicine alongside you, to learn from you, and be
constantly inspired by your dedication-and Lehigh Valley
Hospital's-to the highest standards of scientific and
compassionate care individualized for each and every patient.
I am honored and grateful for the opportunity to serve you and
our great institution as Chairman of the LVH Ethics Committee.
Many thanks to Joseph E. Vincent, MD, my predecessor as
Ethics Chairman-now Vice Chairman-for his astonishing
range of substantive contributions to the ethical environment in
which we practice, his wit, wisdom and support. LVH is a
better place to receive and provide medical care as a result of
the remarkable dedication our academic ethicist, Stephen
Lammers, PhD, Professor of Religion at Lafayette, whose
many years with the LVH ethics program have elevated our
ethical discourse, sharpened our policy language and
strengthened our educational programs. Every active
committee member enriches our consults, monthly meetings
and projects by providing unique experience, perspective and
candor. Special thanks to Nancy Stevens, our longtime
member and recenHy retired Patient Representative.
The Ethics Committee needs more physician-members to
attend our monthly meetings, and to participate in our inpatient
consultations. I invite and encourage you to join our
Committee.
Last but not least, thanks to Troika for inviting me to provide
commentary on the AMA's recent Ethical Guideline E-8.061,
"Gifts to Physicians from Industry: I suggest that you visit the
AMA website to review the Guidelines (also in March 2002
Medical Staff Progress Notesl and official answers to
frequenHy asked questions (from which my commentaries
draw). Concern about maintaining a proper relationship
between medical staff and the pharmaceutical industry is by no
means new to LVH. Dr. David Caccese has long served as
our institutional conscience on this matter. The main purpose
of my writing these commentaries is to encourage you to read
the AMA Guidelines yourself. My views are offered as one
physician's perspective, and with utmost respect for you.
Why be concerned about pharmaceutical influence? There
are, after all, so many other things to worry about as we try to
provide high-quality care despite too little time and too many
obstacles. To borrow a metaphor from the Old West, the
pervasiveness of drug promotion today is such that if
physicians resolved tomorrow to "circle the wagons" to
eliminate it, we would find drug logos printed all over the inside
of the wagon covers! As an experiment, try to go a week

without using or displaying a physical advertisement for a
pharmaceutical product. Specifically, try to make it from
Monday morning to Friday afternoon without writing with a pen,
using a sticky or notepad, or inadvertently carrying an
implement in your lab coat-emblazoned with a drug name or
company logo. Recently, I attended a steering committee
meeting overseeing planning for a large specialty society
annual meeting. One irrepressible colleague, concerned with
the growing industry presence at recent meetings, displayed a
T-shirt he had made with the specialty society's logo
surrounded front and back with drug company logos,
reminiscent of a NASCAR driver's suit. While the intent of his
theatrics was to warn us about future conflicts of interest,
actual and apparent, the most telling irony was that about half
the committee thought the T-shirt was "real·!
The first "buller in the AMA Guidelines E-8.061, "Gifts to
Physicians from Industry" is:

•

Any gifts accepted by physicians individually
should primarily entail a benefit to patients and
should not be of substantial value. Accordingly,
textbooks, modest meals, and other gifts are
appropriate if they serve a genuine educational
function. Cash payments should not be accepted.
The use of drug samples for personal or family
use is permissible as long as these practices do
not interfere with patient access to drug samples.
It would not be acceptable for non-retired
physicians to request free pharmaceuticals for
personal use or use by family members.

The theme of this "buller is the fiduciary duty at the heart of
the physician-patient relationship, namely, that the physician
has a duty to put the interests of patients first. The guideline
allows gifts that "primarily entail a benefit to patients" and serve
a "genuine educational function•, but lays the groundworkdeveloped in subsequent "bullets"-forthe application of these
criteria.
The business interest of pharmaceutical companies is to see
their products chosen over those of the competition. When a
physician accepts gifts that amount to "perks• to the physician
as a physician, studies show these tend to create subtle bias
and product name recognition that may subordinate the
patient's interest. The patient's interest is to receive balanced
information on the most appropriate drug (and non-drug)
alternatives tailored to the patient's specific problem. In ethical
terms, the patient has an autonomy interest in shared decisionmaking with the physician over the trajectory of treatment and
important alternatives. From the patient's perspective, key
parameters include efficacy, cost, side effects and drug
interactions, not hospitality or largesse lavished upon the
patient's physician. In principle, the physician could disclose
(Continued on Page 6)
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the specific gifts received in relation to each drug being
recommended. In practice, this probably occurs rarely, if for
no other reason than that the physician's recollection is usually
not of specific gifts or events attended, but rather a positive
disposition toward a product, which was the very point of the
gift.
The AMA answers to frequently asked questions make the
following helpful points. Diagnostic equipment (e.g.,
stethoscopes) may be accepted as gifts, as they primarily
benefit the patient, if they are "not of substantial value",
measured by what they would cost the physician to purchase.
Invitations to attend a dinner with a speaker-where the
·
company promises to donate $100 to a charity or medical
school on behalf of the physician-are a judgment call, but do
not raise ethical concerns if the "charity is predetermined
without the physician's input". Concerning companysponsored dinners featuring a speaker, the guidelines specify
that the dinner must be a "modest meal," that any gifts (e.g.,
textbooks) primarily benefit patients and not be of substantial
value (i.e., not exceed $100), and that educational component
of the event have "independent value". Specifically, the
presentation should be by an "authoritative speaker" and not a
company sales representative. The "modest meal" should be
"similar to what a physician routinely might have when dining
at his or her expense". (Meals accepted in the office or the
hospital as part of a meeting with a company representative
should likewise be of "nominal value", e.g., a sandwich or
snack.) Vouchers to reimburse physicians for uncompensated
care are not acceptable, because these are direct physician
income. Accumulation of "points" over several educational or
promotional meetings that could be redeemed toward gifts
from an educational catalogue are acceptable only if they do
not add up to a gift of substantial value. Gift certificates for ·
attending educational or promotional meetings are a gray area,
as the guidelines permit medical textbooks or selection from a
medical textbook catalogue. On the other hand, gift
certificates can function as cash if the recipient has an
unlimited number of choices in their redemption. Thus, to
guide physicians in making this judgment call, the AMA
recommends that the number of choices be limited (arbitrarily)
to approximately eight, and the value of the gift finally chosen
not exceed $100.
The following are the AMA's verbatim recommendations on
personal or family use of free pharmaceuticals: They are
permitted "(i) in emergencies and other cases where the
immediate use of a drug is indicated, (ii) on a trial basis to
assess tolerance, and (iii) for the treatment of acute conditions
requiring short courses of inexpensive therapy, as permitted by
Opinion E-8.19: Self-Treatment or Treatment of Immediate
Family Members. It would not be acceptable for physicians to
accept free pharmaceuticals for the long-term treatment of
chronic conditions."
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Please contact me with your questions, suggestions or
concerns.
Glenn A. Mackin, MD
Office: (610) 402-8420

Computer-Based Training (CBT)
Beginning April 2002, the Information Services department will
assume responsibility for the computer-based training (CBT)
programs available to Lehigh Valley Hospital (LVH) staff. CBT
programs replace the instructor-led classes previously held at
LVH. A proctor will be in the room with the learner while
he/she takes the CBT, but the Ieamer will control the pace and
objectives of the learning.
Topics covered by the CBT programs include:
97
97
PowerPoint 97

~Access
~Word

~

~
~

Windows NT 4
GUI Email
~ Excel97

Computer-based training is held in Suite 401 of the John &
Dorothy Morgan Cancer Center (the training room) and in
the Lehigh Valley Hospital-Muhlenberg liS training room
(off the front lobby). The 2002 schedule of classes include:

2002 CBT Sessions •• JDMCC, Suite 401
(All sessions are held from 8 a.m. to noon, unless otherwise
noted.)

April23
July 23
October22

May28
August27
November26

June 25
September 24
December 18 (noon - 4 p.m.)

2002 CBT Sessions .. LVH·Muhlenberg, liS Training Room
(All sessions are held from noon to 4 p.m., unless otherwise
noted.)

May 14
August 15
November21

June 20
July 18
September 19 October 17
December 19 (8 a.m.- noon)

Twelve seats are available at each session. To register for a
session in email, go to either the Forms_ILVH or
Forms_IMHC bulletin board, (based on your choice of site
and training room). The form has all the available information
in an easy to choose format, detailing titles, dates, times, and
locations. Simply do a "Use Form" (a right mouse option) on
the liS Computer Educ Request form. Complete the form
indicating your desired session selection and mail the form.
Shortly, you will receive a confirmation notice.
If you have any questions, please contact Information Services
by calling the Help Desk at (610) 402-8303 and press option
"1. • Tell the representative that you need assistance with liS
education.

Medical Staff Progress Notes
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Radiology News
Mammography
Given the recent controversy regarding the use of screening
mammography, it should be noted that a government task
force has recently come out in support of screening
mammography. Members of the Department of RadiologyDiagnostic Medical Imaging support the recommendations of
the American College of Radiology, the American Cancer
Society, and the American College of Obstetrics and
Gynecology in recommending annual mammography for
women ages 40 and older.
Locally, Breast Health Services has passed MQSA inspection
at all sites in the network with no contingencies (something
that is accomplished by less than 5% of the sites that are
inspected in this country). This includes the sites at Cedar
Crest & 1-78, LVH-Muhlenberg, Allentown Breast Diagnostic·
Center (ABDC), Trexlertown, Bath, Kutztown, and Hamburg.

PET Scan
The Center for Medicare and Medicaid Services has approved
PET scans for staging and restaging of breast cancer as well
as for monitoring response to treatment in women with locally
advanced or metastatic breast cancer. PET scans have been
shown to change clinical stage in 36% and management in
58% of patients with breast cancer according to an article by
Yap et al, Journal of Nuclear Medicine, Vol42, No 9,
September, 2001, pp 1334-1337.
If you believe your breast cancer patient can benefit from a
PET scan, call toll-free 1-866-235-7226 for scheduling. If you
have any questions regarding this issue, please call either
Robert J. Rienzo, MD, or Kathleen L. McDonald, MD, in
Nuclear Medicine at (610) 402-8373.

CCK is Now Available
As you may know, over the past several months, the Section of
Nuclear Medicine was unable to offer patients gallbladder
stimulation studies with cholecystokinin (CCK) because of a
manufacturing problem. Nuclear Medicine is pleased to
announce that they have found a pharmacy in Oklahoma that
makes Sincalide (the chemical form of cholecystokinin), which
is similar to the original product, Kinevac. The new product is
pyrogen free and sterile and is considered to be as safe and
effective as the original Kinevac.
Nuclear Medicine has also altered the method of administering
the CCK in that they now give .02 microgram per kilogram over
a 30 minute timeframe rather than over a three minute
timeframe since this has proven to be more physiologic in the
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recent literature. Nuclear Medicine images the patients over
the course of 30 minutes and calculates the gallbladder
ejection fraction. Values at or above 35% are considered to be
normal. The patient may not experience pain after CCK
infusion even with scintigraphic evidence of gallbladder
dyskinesia.
These studies are typically outpatient studies and may be
scheduled through the Centralized Scheduling Departments at
both Cedar Crest &1-78, (610) 402-8378, and LVHMuhlenberg, (484) 884-2279.

News from Health Information
Management
Physician Query Process
In the circumstance when unclear or conflicting documentation
exists within the medical record, a physician query will be
generated to clarify the diagnosis/procedure.
The physician will provide the requested additional clarifying
documentation via a dictated addendum to the medical record.
The process for the addendum is as follows:
1) Physicians will dictate the query response on transcription
work type ·so• to distinguish the addendum from other
transcriptions. Physicians will need to indicate "Dictate•
for the deficiency.
2) Remember to include the patienfs name, medical record
number, discharge date, and account number.
3) When the physician completes the dictation deficiency,
he/she will need to "hir the complete button, which will
remove the deficiency.
Please remember when addressing the query, the query
form is NOT part of the permanent medical record. One-word
answers or diagnoses will not clarify the present
documentation in the record. Always answer the query in
sentence form (i.e., chest pain secondary to CAD; altered
mental status due to UTI, etc.).
If you have any questions regarding this issue, please contact
Karen Caravetta, CCS, Team Leader, Coding, at (610) 4022874.

Medical Staff Pro ress Notes
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Coding Tip of the Month
Acute Ml: When documenting an acute Ml, it
is important to document "acute Ml" and specify
whether it was subendocardial, non-Q wave
Ml, or nontransmural. If transmural, give
specific site. ST and non ST Mls are not
codeable.
When there are positive troponins or positive
MIP, always specify the etiology of the
abnormal lab findings. For example, acute Ml,
sepsis, renal failure, etc.
CHF: When the diagnosis of CHF is
established, please document the etiology. For
example, if acute Ml, ischemic cardiomyopathy,
medication noncompliance, valvular
dysfunction, CAD, etc.
Pleural Effusion: When there is pleural
effusion, please document the etiology if
known. For example, secondary to CHF, due
to malignancy, secondary to pneumonia, etc.
Pulmonary Edema: It is important to
::ocument whether pulmonary edema is cardiac
on non-cardiac related. When non-cardiac
related, document also the likely cause.
Cardiomyopathy; It is important to document
whether the etiology of cardiomyopathy is due
to hypertension, ischemic disease, vascular
disease, viral illness, or poisoning and whether
it is congenital, hypertrophic, or IHSS.
Angina: Angina is usually a symptom of an
underlying disease process. Please document
the etiology of the angina and whether it is
considered stable or unstable. When
specifying unstable angina, define what makes
it unstable.
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evaluated MRCP and ERCP in patients with sclerosing
cholangitis and normal patients. MRCP was comparable to
ERCP in assessing biliary strictures and superior in
visualization of intrahepatic biliary ducts.
Herbert L. Hyman, MD, Division of Gastroenterology,
presented "Psychosomatic Medicine• to the Department of
Obstetrics and Gynecology at The Reading Hospital and
Medical Center in late February.
Peter A. Keblish, Jr., MD, Division of Orthopedic Surgery,
Section of Ortho Trauma, published an article in Orthopaedics
supplemental February 2002 issue. The article was "Alternate
Surgical Approaches in Mobile-Bearing Total Knee
Arthroplasty. •
lndru T. Khubchandani, MD, Division of Colon and Rectal
Surgery, was an invited participant at the IV International
Pelvic Floor Dysfunction meeting, held in Taormina, Sicily from
March 12 to 16, where he gave a lecture on "Intra-rectal Ultra
Sound" and chaired and moderated sessions on various pelvic
floor disorders.
Howard S. Selden, DDS, Division of Endodontics, authored
the paper, "The Dental-Operating Microscope and Its Slow
Acceptance,• which was published in the March, 2002 issue of
the Journal of Endodontics.

Upcoming Seminars, Conferences and
Meetings
Medical Grand Rounds
Medical Grand Rounds are held every Tuesday beginning at
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest
& 1-78, and via videoconference in the First Floor Conference
Room at LVH-Muhlenberg. Topics to be discussed in April will
include:
~

~
~
~

Papers, Publications and Presentations
Kelly M. Freed, MD, Division of Diagnostic Radiology,
published an article, "Comparison of MR
Cholangiopancreatographic Techniques with Contrastenhanced Cholangiography in the Evaluation of Sclerosing
Cholangitis,• which was published in the February, 2002
edition of the American Journal of Radiology. The article
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~

April2- "HIV and Kidney Disease•
April 9 - "The Challenges of Managing the Injured Worker"
April16 - "Clinical Aspects of Systemic Sclerosis
(Scleroderma)"
April17* Special Medical Grand Rounds - "Maximizing the
Interview"
April 23 - "New Advances in Steroid Management of IBD"
April30- "Airway Remodeling- Fact or Fiction"

For more information, please contact Diane Biernacki in the
Department of Medicine at (610) 402-5200.
(Continued on Page 9)
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(Continued from Page 8)

Department of Pediatrics
Pediatric conferences are held every Tuesday beginning at 8
a.m., in the Auditorium of Lehigh Valley Hospital, Cedar Crest
& 1-78. Topics to be discussed in April will include:
}
}
}
}
}

April2- ·case Presentation•
April 9 - ·current Management of Bums•
April16 - "Chiere I Malformation"
April 23 - •case Presentation•
April 30 - •Attention Deficit Hyperactivity Disorder"

For more information, please contact Kelli Ripperger in the
Department of Pediatrics at (610) 402-2540.

Psychiatry Grand Rounds
"An Integrated Approach to IBS Objectives• will be presented
on April18, from noon to 1 p.m., at LVH-Muhlenberg, in the 4111
Floor ER Conference Room.
If you have any questions or for more information, please
contact Audrey Mclaughlin in the Departmen~ of Psychiatry at
(484) 884-6501.

Who's New
The Who's New section of Medical Staff Progress Notes
contains an update of new appointments, address changes,
resignations, etc. Please remember to update your directory
and rolodexes with this information.

Medical Staff
Appointments
Fred J. Bonacci, DMD
In practice with Joseph R. Loiacono, Jr., DDS
764 Main Street
Peckville, PA 18452-2306
{570) 383-2411
Fax: (570) 383-6954
Department of Dental Medicine
Division of General Dentistry
Provisional Active
Site of Privileges - LVH & LVH-M

Barbara C. Cavanaugh, MD
Medical Imaging ofLV, PC
Lehigh Valley Hospital
Cedar Crest & 1-78, P.O. Box 689
Allentown, PA 18105-1556
(610) 402-8088
Fax: (610) 402-1023
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology
Provisional Active
Site of Privileges - LVH & LVH-M
Kathya M. Darmos, DPM
Kramer &Maehrer LLC
2597 Schoenersville Road, Suite 304
Bethlehem, PA 18017-7309
(610) 868-6353
Fax: (610) 694-9719
Department of Surgery
Division of Podiatry
Provisional Active
Site of Privileges - LVH &LVH-M
James F. Frommer, Jr., DO
(Solo Practice)
65 E. Elizabeth Avenue, Suite 206
Bethlehem, PA 18018-6506
(610) 691-8537
Fax: (610) 691-8420
Department of Family Practice
Provisional Active
Site of Privileges - LVH & LVH-M
Ann M. McGeehan, MD
Medical Imaging of LV, PC
Lehigh Valley Hospital
Cedar Crest &1-78, P.O. Box 689
Allentown, PA 18105-1556
(610) 402-8088
Fax: (610) 402-1023
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology
Provisional Active
Site of Privileges - LVH &LVH-M
Douglas D. Semian, MD
LVH Department of Medicine
Lehigh Valley Hospital
Cedar Crest &1-78, P.O. Box 689
Allentown, PA 18105-1556
Department of Medicine
Division of General Medicine
Provisional Limited Duty
Site of Privileges - LVH & LVH-M
(Continued on Page 10)
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Change of Address

Status Changes

Eva R. Michael, MD
2527 East Texas Blvd.
Allentown, PA 18103-2899
(610) 820-0477
Fax: (610) 434-7332

Harvey S. Cheng, MD
DepartmentofSu~e~

Division of Ophthalmology
From: Active
To: Affiliate
Site of Privileges - None
Thomas B. Dickson, MD
Department of Su~ery
Division of Orthopedic Surgery
From: Active
To: Honorary
Mark N. Martz, MD
Department of Su~ery
Division of Cardia-Thoracic Surgery
Section of Thoracic Surgery
From: Affiliate
To: Honorary
Joseph T. Sembro~ MD
Department of Medicine
D1vision of Endocrinology
From: Affiliate
To: Honorary
Nora A. Suggs, MD
Department of Su~ery
Division of General Su~ery
From: Active
To: Honorary

One-Year Leave of Absence
Francis S. Kleckner, MD
Department of Medicine
Division of Gastroenterology
From: Active
To: Active/LOA

Phone Number Change
Peter T. Ender, MD
Jeffrey A. Jahre, MD
Thong P. Le, MD
(610) 954-4000

Page 10

William A. Ofrichter, DPM
2030 Center Street, Suite 101
Northampton, PA 18067-1321
(610) 261-1001
Fax: (610) 261-2589
Robert W. Vaughn, MD
8360 Holbens Valley Road
New Tripoli, PA 18066-3506
(610) 298-2959

Change of Practice/Address
Maria Jones, MD
Bmdjar &Freeman Medical Associates, PC
4 W. Main Street
Macungie, PA 18062-1309
(610) 967-4993
Fax: (610) 967-6553
Martin LeBoutiller Ill, MD
Chester County Cardiovascular Surgical Associates
701 E. Marshall Street
West Chester, PA 19380-4412
(610) 738-2690
Fax: (610) 738-2696
Joseph B. Lennert, MD
Northgate Urology Associates
5325 Northgate Drive, Suite 203
Bethlehem, PA 18017-9410
(610) 867-3171
Fax: (610) 867-1941
John B. Paulus, DO
Lehigh Internal Medicine Associates
Atrium Building
2895 Hamilton Blvd., Suite 101
Allentown, PA 18104-6192
(610) 439-0303
Fax: (610) 439-1157
Robin A. Skrine, MD
Breast Care Specialists, PC
1240 S. Cedar Crest Blvd., Suite 205

Allentown, PA 18103-6218
(610) 433-7700
Fax: (610) 433-8014
(Continued on Page 11)

Medical Staff Pro ress Notes
(Continued from Page 10)

Resignations
Samuel Abramovitz, MD
Department of Obstetrics and Gynecology
Division of Primary Obstetrics and Gynecology
Alan W. Johnson, MD
Department of Family Practice
Joe Lee, MD
Department of Medicine
Division of Physical Medicine-Rehabilitation
Orazio Prestifilippo, MD
Department of Family Practice
Harvey T. Starr, DO
Department of Medicine
Division of General Internal Medicine

Allied Health Professionals
Appointments
Frederick C. Ackler, CRNA
Physician Extender
Professional - CRNA
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin,
Jr., MD)
Site of Privileges - LVH & LVH-M
Theresa M. Godshall, CRNA
Physician Extender
Professional - CRNA
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin,
Jr., MD)
Site of Privileges - LVH & LVH-M
Wendy A. Grose, CRNA
Physician Extender
Professional- CRNA
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin,
Jr., MD)
Site of Privileges - LVH &LVH-M
Carol J. Hornbuckle, RN, CRNFA
Physician Extender
Professional - Certified Registered Nurse First Assistant
(Orthopaedic Associates of Allentown - Patrick J. McDaid, MD)
Site of Privileges - LVH & LVH-M
Zanetta L. Keddie, PA-C
Physician Extender
Physician Assistant- PA-C
(Coordinated Health Systems - Leigh S. Brezenoff, MD)
Site of Privileges - LVH-M
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Judith A. Madaus, CRNP
Physician Extender
Professional - CRNP
(Valley Gastroenterologists - Richard L. London, MD)
Site of Privileges - LVH & LVH-M
Liese K. Marshall, CRNA
Physician Extender
Professional - CRNA
(Lehigh Valley Anesthesia Services- Thomas M. McLoughlin,
Jr., MD)
Site of Privileges - LVH &LVH-M
Jonathan L. Matzko, CNIM
Physician Extender
Technical-Intraoperative Neurophysiologic Monitoring
Specialist
(Surgical Monitoring Associates, Inc.)
(Supervising Physician - Mark C. Lester, MD)
Site of Privileges - LVH & LVH-M
Sergio Rudio, Jr., PA-C
Physician Extender
Physician Assistant- PA-C
(Coordinated Health Systems - Wayne T. Luchetti, MD)
Site of Privileges - LVH-M
Therese L. Schiowitz, CRNA
Physician Extender
Professional - CRNA
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin,
Jr., MD)
Site of Privileges - LVH &LVH-M
Patricia A. Vaccaro, CRNP
Physician Extender
Professional - CRNP
(Wound Healing Center- William R. Dougherty, MD)
Site of Privileges - LVH &LVH-M
Change of Supervising Physician

Patricia M. Frey, RN
Physician Extender
Professional - RN
(The Heart Care Group, PC)
From: Steven L. Zelenkofske, DO
To: David B. Goldner, MD
Site of Privileges - LVH &LVH-M
Susan E. Kunsman, CRNP
Physician Extender
Professional - CRNP
From: Daniel E. Ray, MD- Pulmonary Associates
To: Donald J. Belmont, MD- The Heart Care Group, PC
Site of Privileges - LVH & LVH-M
(Continued on Page 12)
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Resignations

Mark A. Sabatino
Physician Extender
Technical- Pacemaker/ICD Technician
(Guidant Corporation)
From: Steven L. Zelenkofske, DO
To: Bryan W. Kluck, DO- The Heart Care Group, PC
Site of Privileges - LVH & LVH-M

Bonita L. Budura, CRNA
Physician Extender
Professional- CRNA
(Allentown Anesthesia Associates Inc.)

Sandra K. Stufflet, RN
Physician Extender
Professional - RN
(The Heart Care Group, PC)
From: Steven L. Zelenkofske, DO
To: David B. Goldner, MD
Site of Privileges - LVH & LVH-M
Cheryl A. Tyler, RN
Physician Extender
Professional - RN
(The Heart Care Group, PC)
From: Steven L. Zelenkofske, DO
To: David B. Goldner, MD
Site of Privileges - LVH & LVH-M
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Lori A. Emerich, CRNP
Physician Extender
Professional - CRNP
(The Heart Care Group, PC)
Francisco X. Lanas, PA..C
Physician Extender
Physician Assistant- PA-C
(Coordinated Health Systems)
Marie T. Myer, RN
Physician Extender
Professional - RN
(The Heart Care Group, PC)
Baoqing Wang, DABNM
Associate Scientific
Clinical Neurophysiologist
(Surgical Monitoring Associates)
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The Last Word ...
Tips and Techniques for the Lastword ... User

April, 2002- Volume 1, Issue 6

Medication Order Conflicts
by Carolyn K. Suess, R.N.
Physicians using CAPOE to order
patient medications are undoubtedly
familiar with the appearance of
Medication Order Conflict screens. If a
medication is ordered in CAPOE and a
conflict of drug allergy, duplication, or
interaction exists, the Medication Order
Conflict warning appears (Figure 1).
Each of these three types of conflicts is
discussed in the following paragraphs.

Therapeutic Duplicates
A Therapeutic Duplicate conflict
indicates the medication is in the same

drug class as a previously ordered
medication. The medication appears in
the Duplicating/Interacting Drug List
portion of the screen, providing the dose,
and start and stop dates/times (see Figure
1).

You have three options to consider with
a therapeutic duplicate:
1. You may discontinue the previously

ordered medication
2. You may override the coriflict
3. You may skip the order you are
attempting to place
To discontinue the previously ordered

Figure 1 -Medication Order Conflict for a therapeutic duplication

Page 14
side of the Medication Order Conflicts
screen (Figure 1).

medication, click on the pull-down list
adjacent to the medication and doubleclick on Discontinue as shown in Figure
1. Click on the Process Actions button
located at the bottom left side of the
screen to complete the action. The
Discontinue an Order screen opens,
prompting you to select the appropriate
discontinue reason (Figure 2). Doubleclick on the desired discontinue reason,
then click on the Send button located on
the bottom left side of the screen.

If you wish to skip the order, click on the
Skip Order button, located on the
bottom right side of the screen (see
Figure 1).
Drug Allergy Conflicts

A drug allergy conflict indicates the
patient has an allergy to the ordered
medication. Allergies and reactions are
listed under the Allergies/Reactions
portion of the screen (see Figure 3).

If you wish to override the conflict
warning, simply click on the Place
Order button located on the bottom left

13

~;ill Discontinue an Order

r Current Order I n f o n n a t i o n - - - - - - - - - - - - - - - - - - ,

I MORPHINE SULFATE
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P0102
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Ordered
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Cancel- Error/Changed My Mind

Send

xit Discontinue

Figure 2 - Discontinue an Order screen
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Drug Interactions

There are two options to consider with a
drug allergy alert:

If the medication you are ordering
interacts with one that had been ordered
previously, a drug interaction conflict
screen appear (Figure 4).

1. You can skip the order you are
attempting to place
2. You can override the conflict and
place the order

You have three options to consider with
a drug interaction:

Should you wish to skip the order you
are attempting to place, click on the Skip
Order button located on the bottom
right side of the screen.

1. You may discontinue the previously
ordered medication
2. You may override the conflict

If you determine that the allergy or
reaction is not severe enough for the
medication to be contraindicated, you
may override the conflict. To do so,
click on the Place Order button located
on the bottom left side of the screen.
L'.:JUOIU0200ZITHHU M"'

3. You may skip the order you are
attempting to place
To review information regarding a drugdrug interaction, click on the pull-down
list and select Display Interaction
tllli!!J

M

>

Figure 3 - Medication Order Conflict for a drug allergy
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Monograph (see Figure 4). If available,
it will list severity, mechanism of action,
and references.

right side ofthe screen.
If you determine that the drug interaction
is not severe enough for the medication
to be contraindicated, you may override
the conflict. To do so, click on the Place
Order button located on the bottom left
side of the screen.

To discontinue the previously ordered
medication, click on the pull-down list
adjacent to the medication and doubleclick on Discontinue (Figure 4). Click on
the Process Actions button located at
the bottom left side of the screen to
complete the action. The Discontinue an
Order screen opens (Figure 2),
prompting you to select the appropriate
discontinue reason. Double-click on the
desired discontinue reason, then click on
the Send button located on the bottom
left side of the screen.

For more information on the Medication
Order Conflicts and other Lastword
features, please take a moment to review
the on-line documentation for Lastword.
Both the CAPOE and Non-CAPOE
Physician User Guides can be found on
the LVHNN Intranet under the
Resources heading Lastword for
Physicians.

Should you wish to skip the order you
are attempting to place, click on the Skip
Order button located on the bottom
Ej00100200ZilHRO Ma<

For questions or comments regarding the
CAPOE module in Lastword, please
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contact one of the Physician Software
Educators on staff:

substitutions, maximum dosing
parameters, and creatinine clearance
estimates. These modifications were
created to provide additional safety,
clinical information, and cost
containment when placing orders online. Each is discussed in the following
paragraphs.

Lynn Corcoran-Stamm- ext. 1425
Kimberlee Szep, R.N.- ext. 1431
Carolyn K. Suess, R.N.- ext. 1416
If you have training needs that pertain
only to the Lastword system, please
call ext. 1703. Arrangements can be
made for training at your convenience.

Therapeutic Substitutions
Therapeutic substitutions are designed to
provide therapeutic alternatives at a
lesser cost or during times of product
shortages. Presently, there are
approximately 50 therapeutic
substitutions in CAPOE. The system
keeps the physician informed while
placing orders and making clinical
decisions.

CAPOE Medication Order
Enhancements
by Carolyn K. Suess
CAPOE users may have recognized
some enhancements added to medication
orders. Among these are therapeutic
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An example of such a substitution would
be famotidine for cimetidine. Upon
selecting cimetidine under Medications
A-L on the CAPOE Order Pad, a screen
appears listing the drug that is ordered,
and one that is available, in this instance
famotidine (see Figure 5). The screen
provides comparative dosing
infonnation for each drug and
therapeutic options.

closes and the selected therapeutic
substitute appears in the Unprocessed
Orders window ofthe CAPOE Order
Pad. To process the order, click on the
Process Orders button located beneath
the Unprocessed Orders window.
If the therapeutic alternative famotidine
is not desired, click on the Back button
to return to the order screen, and contact
the phannacy to request cimetidine.

With this scenario, let us presume the
physician wished to order cimetidine,
400 mg, PO, BID. The therapeutic
equivalent would be famotidine, 20 mg,
PO, BID. To place the famotidine order,
the physician would click on the
appropriate dose listed under the
Therapeutic Options portion of the
screen, then click on the Select button
located beneath the doses listed (see
Figure 5). You may a&o double-click on
the medication to select it. The screen

Maximum Dosing

Maximum dosing parameters are
presently in place for over 1,000
medications at Lehigh Valley Hospital.
When placing a CAPOE medication
order, this safety enhancement provides
dosing infonnation when a maximum
single dose, total daily dose, or dose
based on weight is exceeded.

Figure 6 - Acetaminophen order displaying maximum single dose warning on status bar
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The example shown in Figure 6 displays
an order for acetaminophen, 6500 mg,
PO, Q6H, PRN. Upon attempting to
place the order, a warning on the status
bar located on the lower left margin of
the screen appears. The warning states
the maximum single-dose for
acetaminophen (1 000 mg) has been
exceeded. The maximum dose warning
does not prevent the physician from
placing the order, but is only
informative.

concerning CAPOE or Expert Rule
development with Dr. Donald Levick.
Dr. Levick can be paged at (610) 4025100, ID #7481.

Creatinine Clearance Estimates
Creatinine clearance is used to adjust
dosages for renally eliminated drugs, or
to monitor patients on nephrotoxic
drugs. By providing a creatinine
clearance estimate upon placing a
medication order, the physician can
adjust medication dosing as indicated.
Presently, there are five medications that
provide an estimated creatinine
clearance when ordered:

Figure 7 -Creatinine Clearance Estimation

CAPOE: Fact vs. Fiction

Meperidine (Demerol)
Gentamicin
Tobramycin
Levoftoxacin (Levaquin)
Metformin HCI (Giucophage)

by Carolyn K. Suess. R.N.

In the February 2002 issue of The Last
Word, an article titled CAPOE: What's it
All About? attempted to dispel some
preconceived notions regarding
Computer Assisted Physician Order
Entry. With the recent activation of
CAPOE on 6B, here are a few more
myths that should be added to the list:

Upon placing an order for one of these
medications, an alert appears displaying
the patient's most recent serum
creatinine, body weight, height, age, sex,
calculated ideal body weight, and the
creatinine clearance estimate based on
the Cockcroft-Gault formula (see Figure
7).

Myth #1: As a CAPOE user, I
cannot activate a patient by
Medical Record Number in the
Lastword system

The system enhancements discussed in
the previous paragraphs are a direct
result of physician feedback. That is why
your input is so important. Please take a
moment to share your thoughts and ideas

Although patient lists are available for
use in the Lastword (Phamis) system,

you do have the option to search for a

7
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patient by medical record number.
Simply click on the MRN search field
located under the Patient Lookup area of
the Physician Base screen (see Figure 8).
After entering in the patient medical
record number, click on the Name
Lookup button. If the entry was entered
correctly, the patient will activate and
his or her first and last names, account
number, room and bed will populate the
remaining fields in the Patient Lookup
area of the screen.
Myth #2: Now that I am trained to
enter orders in CAPOE on 68, I
won't have any support

CAPOE user support on 6B will be
available from the date of unit activation
until the end of March, 2002, after which
CAPOE assistance is but a phone call
away. Simply dial ext. 8303, and select
option #9. The on-call CAPOE

trainer/analyst will return your call
immediately.
Following 6B, user support will then
move to 7B for the Electronic Vital
Signs/Medication Administration, and
CAPOE activation during the month of
April, 2002.
Myth #3: CAPOE prevents
medication renewals from working

The medication renewal process falls
outside of the CAPOE system. The
renewal of a medication precipitates
from the yellow sheet sent by Pharmacy
and placed on the patient's chart. A
renew notification also displays on-line
in the CAPOE Order Profile screen.
These notifications are an enhancement
to the current process that is already in
place.

Enter patient medical
record number here

Figure 8- Physician Base screen showing MRN field under Patient Lookup area
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April2002
NEWS FROM THE LmRARY
Computer-Based Training (CBT):
OVID Instruction.
Contact Barb Iobst at 61 0-402-8408 to arrange for instruction
in the use of OVID's MEDLINE and its other databases.
Access to the L VH-Muhlenberg Library

Computer Based Training (CBT} programs are available for
LVHHN staff. Topics covered by the CBT programs include:
Power-Point 4.0
Access 2.0
Windows NT 4
Word 97
Excel 97
Access 97
PowerPoint 97
Lotus 1-2-3 Millennium
WordPerfect 8
E-mail GUI
PHAMIS LastWord Inquiry Only commands

For the past several months card access was the only way to
enter the library. The door is now unlocked when the library
is staffed. Suzanne Rice is generally available in the library
from 8:00 am-4:30PM Monday-Friday. Her hours may
fluctuate due to assignments in another part of the building, or
due to PTO. Her phone number is 484-884-2237. Her pager
number is #1265.

CBT programs replace the instructor-led classes previously
held at Lehigh Valley Hospital. A proctor will be in the room
with the learner while he/she takes the CBT, but the learner
will control the pace and objectives of the learning.

As in the past you can contact the library at the Cedar Crest
site directly if you need a MEDLINE search done or a copy of
an article that is not available in the LVH-Muhlenberg library.
The main phone number at the Cedar Crest library is 610402-8410. The fax number is 410-402-8409.

Computer Based Training takes place in Suite 401 of the
John & Dorothy Morgan Cancer Center {the computer
training room) and in the Muhlenberg Hospital Center
computer training room (off the front lobby). The schedule
of upcoming dates is as follows:

Recently Acquired Publications.

CBT sessions for JDMCC, suite 401 are as follows:
April 23, Sam - noon

Library at 17tt. and Chew Streets
Ebersole. Geriatric Nursing and healthy Aging. 2001

Sessions at MHC, I.S. Training room are as follows:
May 14, noon- 4pm

Lee. Medical Care of the Pregnant Patient. 2000
Twelve slots are available for each session.
Library at CC & 1-78 Campus

To register, please contact Suzanne Rice via e-mail or at 610402-2475 with the following:
date of session
second date choice
department
phone number
You will receive an e-mail confirming your choice within two
business days. If you have any questions, please contact Craig
Koller at 610-402-2413 or through e-mail.

Gunter. Dallas Rhinoplasty 2 vol. set. 2002
DeVita. Cancer. 2002

Library at LVH-Muhlenberg
Simon. Emergency Procedures and Techniques. 2001
Garratt. Mechanisms and Management of Cardiac
Arrhythmias. 2001

1

Any questions, concerns or comments on articles from CEDS, please contact
Bonnie Schoeneberger 610-402-2584
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THERAPEUTICS AT A GLANCE
The following actions were taken at the February 2002 Therapeutics Committee Meeting- Joseph Ottinger, R.Ph., MS, MBA, Janine
Barnaby, R.Ph., Jenny Boucher, Phann.D., Jason, Laskosky, Phann.D., Viraj Patel, Pharm.D,

Adverse Drug Reaction
The use of low molecular weight heparins (LMWH) continues to increase. Generally, they have been shown to be
as effective as unfractionated heparin (UFH) in preventing and treating a variety of thrombotic disorders.
However, as with all anticoagulants they may also elicit unwanted bleeding effects, most of which are minor. The
safety profile for these drugs has been well studied in controlled patient populations and based on these data,
prescribed dosing schemes have been identified for treatment and prophylactic uses of these agents. Appropriate
levels of anticoagulation are assumed, if these dose schedules are utilized. This eliminates the need to routinely
monitor the usual laboratory coagulation parameters., which are essentially useless in assessing the anticoagulation
status of patient's receiving low molecular weight heparins. Use of 'alternative' dosing strategies or use in
populations that were not studied may place the patient at risk for bleeding and/or thrombotic events. Previous
ADR (Adverse Drug Reaction) reports described here have identified patients that have had bleeding episodes, who
were renally compromised (estimated creatinine clearance< 30 ml/min.).
In this quarter's data, we reviewed the cases oftwo patients who developed a spontaneous spinal hematoma, while
being anticoagulated. The common elements of both cases were use of a low molecular weight heparin, both were
female and greater than 60 years old. Initially, both patients complained of back pain which was treated with
injectable ketorolac. Each received two doses of this non-steroidal anti-inflammatory drug before complaining
about lost sensation and an inability to move their lower limbs. The patients subsequently required decompression
laminectomies. Neither patient had any clinically significant renal function issues. A summary of these cases are
outlined below.
...;;.___
Patient A, was admitted to the hospital for suspected TIA and atypical chest pain (73yo ). She had received 3 daily
doses ofwarfarinlOmg during her initial period of hospitalization (INR=l.2) at which point the LMWH was
discontinued (4 doses administered over 2 days). The anti-platelet agents clopidogrel and aspirin were then started
and the warfarin discontinued around day 3. The patient's event occurred 24 hours after this latter medication
change.
Patient B, (60yo) had received a LMWH as an outpatient and was admitted to the hospital for elective surgery and
was started on unfractionated heparin (highest aPTI achieved =91 sec). This patient's event occurred@ 28 hours
post admission.
With the exception of the use ofLMWH around epidural anesthesia and analgesia, these agents have not been
largely associated with spinal hematomas. Horlacher, et al had previously identified the use of antiplatelet agents
and LMWH as possibly adding to the risk of epidural hematomas in patients receiving epidural analgesia. It would
appear from these reports that the use ofketorolac and LMWH should be undertaken with caution in elderly
females.

ADR Reporting
The 4th quarter of2001 saw an increase in the number of ADR's reported. 82 reports were generated
with the top categories being antibiotics, anticoagulants and narcotic analgesics. There were 12 severe reports that
are summarized below:
Patient 1 is a 60 yo who was admitted to the ED for a large drop in his hemoglobin. PTA he was taking rofecoxib
and upon exam was found to have inflammation of his gastric mucosa and ulcer debris. He was supported with IV
fluids, blood transfusions and IV pantoprazole. His hemoglobin returned to normal and he was discharged.
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Patient 2 is a 78 yo discharged on IV penicillin but developed a fever and urticarial rash on arms and trunk.
Patient's therapy was changed to vancomycin and the patient's symptoms improved.
Patient 3 is a 45 yo admitted for angioplasty and eptifibatide and heparin were given according to protocol. Later
the patient became diaphoretic and nauseated with EKG changes. Eptifibatide and heparin were stopped and
patient was taken to the OR and @180m! of pericardia! fluid was extracted.
Patient 4 is a 44 yo who presented from another institution with an embolic CV A. Intra-arterial TP A, heparin and
warfarin were initiated and shortly thereafter a left-sided hemiplegia was found. The medications were stopped due
to the bleed, but the warfarin and heparin were initiated a few days later and the patient improved.
Patient 5 is a 69 yo who presented from another institution with a diffuse petechial rash which developed into skin
sloughing and oral lesions after taking Bactrim. He was transferred to LVH for bum management. He was
aggressively hydrated, given antibiotics and wound care for TENS. A Med Watch was completed.
Patient 6 is a 76 yo transferred from another institution with chest pain and increased troponin and at LVH
underwent an angioplasty where eptifibatide was initiated. Post procedure she developed hematemesis and
eptifibatide was stopped. An upper GI bleed was found and patient was started on high dose IV pantoprazole.
Patient 7 is a 64 yo admitted with mental changes secondary to leukemia. She was started on asparaginase for
leukemia and after receiving a few doses had an anaphylactic reaction. She was given IV diphenhydramine and
hydrocortisone and returned to baseline within 1 hour.
Patient 8 is a 74 yo admitted from another institution who underwent emergency catheterization. He had received
a dose of tenectoplase previously and at L VH received standard doses of abciximab, heparin, aspirin and
clopidogrel. Over a 9-hour period, the patient developed hypotension and a drop in hemoglobin of 3 gm/dl. His
medication were held and was given 2 units of blood. Patient made a full recovery.
Patient 9 is a 74 yo discharged from LVH on levofloxacin. He presented to the ED with a 3-day history of
weakness. Lab fmdings revealed elevated hepatic enzymes. Levofloxacin was discontinued and Zithromax was
begun. His labs returned to baseline and the patient was transferred to TSU.
Patient 10 is a 76 yo admitted to the ED with altered mental status changes due to Pergolide. The medication was
begun 2 days prior to admission and there had been a decrease in muscle movement and a decrease in intellectual
response. The pergolide was stopped and over the hospital course her mental status returned to baseline.
Patients 11 and 12 are discussed following this section.

Pantoprazole Autosub Amended
Based on the new renal dose adjustments now recommended for famotidine, patients receiving IV pantoprazole for
non-GI bleed or non-GERD indications and having an estimated creatinine clearance of< 50 mVmin will be
changed to famotidine 20mg IV daily. This will eliminate the need to call physicians to implement this 'automatic'
substitution. Patients with an estimated creatinine clearance of 50 ml/min or more will continue to receive 20mg of
famotidine every 12 hours.

Automatic Substitution for Meperidine (Demerol)
The Therapeutics Committee approved the policy to automatically substitute meperidine with morphine. The
exceptions are any treatment or prevention of rigors induced by blood products or drugs ( eg. Amphotericin B,
platelets), postanesthesia shivering, and documented allergy to morphine. The primary problem is the accumulation
of the toxic metabolite, normeperidine, particularly in the elderly and in patients with renal function impairment.
This can cause anxiety, tremors, myoclonus, agitation, and seizures. Actually, accumulation has also been observed

Page25
in young, otherwise healthy patients given sufficiently high doses. In addition, meperidine has a ceiling effect.
Higher doses and more frequent administration have little impact on pain relief and may be associated with
increasing side effects. As a result of these problems, meperidine wiJJ be removed from the narcotic floor stock in
all areas except the OR. The substitution is listed below.
Discontinue: Meperidine
mg IVliM every
hours
(and Hydroxyzine or Promethazine, if ordered as part of pain therapy)
Substitute: Morphine Sulfate -----'mg IVliM every _ _ _ _hours
Meperidine
(Demerol)
Morphine

25mg

50mg

75mg

100 mg

4mg

6mg

8mg

lOmg

Revision of the Ceftriaxone to Cefotaxime Automatic Substitution
In light of current recommendations, the policy for dose reductions in ceftriaxone to cefotaxime automatic
substitutions will be amended to the following:
Per Therapeutics Committee policy, discontinue Ceftriaxone (Rocephin) 1 g IV Q24h and begin:
Cefotaxime (Claforan) 1 g IV q8h
For patients with CrC1~30 mllmin,
Cefotaxime (Claforan) 1 g IV q 12h
For patients with CrCl.5 10 mllmin
Cefotaxime (Claforan) 1 g IV q24h

No Dosage Ranges for Pain Medications
After our JCAHO survey in December 2000, we were notified, that dosage ranges CANNOT be written for pain
medications. (eg. Morphine 2-4mg IV or Tylenol #3 1-2 tabs). These orders are left to interpretation by the nurse
and cannot be acted upon.
Medication orders that have a dosage range and corresponding parameters (eg. BP, HR, etc) are acceptable.
If an order is written for a pain medication with a dosage range, either nursing or pharmacy will contact you to
clarify the order.
All preprinted order forms are or have been changed, to comply with JCAHO regulations.

"That's what it says: 'one tablespoonful,

300 times a day."'
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Health Network

PHLEBOTOMY I SAFETY

LABORATORIES

LAB-LINK
Information and Advice About Our Laboratory

Health Network Laboratories (HNL), along with LVHHN, began using
plastic collection tubes for blood specimens approximately two years ago.
Since that time, a dramatic increase in the use of lavender (purple)
pediatric size tubes has occurred.
A safety concern arises when lavender capped pediatric tubes are utilized:
Contents must be manually decanted into larger sized tubes prior to testing.
Removing caps not only presents a safety issue, but may also affect testing
turn around time.

Standard size plastic lavender top tubes yield a 3ml sample when
completely filled. This volume is exactly the same as that of a pediatric
size tube.
At HNL we are continually striving to maintain the highest safety standards
while providing you with the best possible service. If you have any
phlebotomy or safety questions, please call Customer Care at 610-402-8170.
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February 15, 2002

URGENT- FOR PHYSICIAN'S PERSONAL ATTENTION
Subject: Suicide Prevention- Fully Informed Consent With Accutane
Dear Doctor:
On December 5, 2000, the Committee on Government Reform, which I chair, conducted
a hearing regarding the potential link between the acne drug Accutane and depression and
suicide. Accutane (isotretinoin) is a drug approved by the FDA to treat the most serious form of
acne -- a type that is painful, permanently disfiguring, and does not respond to other acne
treatments. However, the FDA has recognized that this medication has a serious and potentially
dangerous side effect. In some instances, Accutane users become severely depressed and
vulnerable to thoughts of suicide.

To date, the Food and Drug Administration (FDA), through its MedWatch reporting
system, has received reports of 140 suicides, 176 suicide attempts, and 1,156 serious depressionrelated events related to Accutane. Many of these reports were for adversely affected teenagers.
Given that MedWatch is a voluntary reporting system and that FDA officials in the past have
suggested that only between one and ten percent of adverse events are reported, the actual
numbers may be much higher.

In February 1998, the FDA issued warnings to physicians and advised the manufacturer,
Roche Pharmaceuticals to include the following warning in the labeling:
"Psychiatric Disorders: Accutane may cause depression, psychosis and, rarely,
suicidal ideation, suicide attempts and suicide. Discontinuation ofAccutane
therapy may be insufficient; further evaluations may be necessary ... ofpatients
reporting depression, some reported that the depression subsided with
discontinuation of therapy and recurred with reinstitution of therapy. "
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At our Committee hearing, we heard testimony from a number of families whose children
had either committed suicide or made an attempt while using Accutane. In their testimony, these
families raised two serious concerns. The purpose of this letter is to share these concerns with
you in hopes that it will help you better address these issues with your patients.
1. While Accutane is meant as a treatment of last resort, it is sometimes prescribed before

trying alternatives with less serious side effects:
The FDA approved Accutane for use for severe nodular cystic acne. The FDA-approved
labeling specifically highlights that this product is not to be considered as a product of first
choice:
"Because ofsignificant adverse effects associated with its use, Accutane should
be reserved for patients with severe nodular acne who are unresponsive to
conventional therapy, including systemic antibiotics. "
However, we learned from witnesses that Accutane is sometimes being used for less
severe forms of acne and before other treatments have been tried.
Michael Bauman, who lost his son Dan to suicide while on Accutane, testified about
running into a friend who was picking up a prescription for Accutane:
"When I asked her if she was aware of the potential side effects, she looked at me
like I was nuts. When I asked if she was counseled by her son 's dermatologist;
she said she was not. I asked if this drug was prescribed when other drugs had
failed and found out that it had been prescribed first before any other remedies
had been tried. I then asked to look at the labeling and letter that came with her
prescription and found that it made no mention of depression or suicide and the
pharmacist said nothing about these potential dangers. "
Mr. Charles Stone, whose son Clay died in January 2000, stated:
"In October 1999, at the age of 16, his treating physician decided to put Clay on
Accutane for his mild acne. "

2. Patients and their parents are not always advised by their physicians of the serious side
effects associated with Accutane:
Tragically, we learned that families had not been fully informed about the suicide risks
associated with Accutane. The FDA's warning to physicians was sent in February 1998. As we
learned during our hearing, patients who ~ere prescribed Accutane after this were not
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always informed of this new warning by their physician. Daniel Bauman began taking Accutane
in June 1999 and received two brochures to review prior to beginning therapy. Neither brochure
mentioned depression or suicide. Daniel committed suicide in December 1999. His mother,
Mrs. Bauman, testified:
"I got on line and used the two key words: Accutane and suicide and found the
FDA's MedWatch News dated February 26, 1998: 'important new safety
information about Accutane. ' In addition, I also discovered that the brochures
Daniel's dermatologist gave us were copywritten in 1996 and 1997, respectively.
The brochures had no adverse reactions reporting depression, psychosis, suicidal
ideations, suicide attempts and suicide. I was finding it very hard to believe that
Daniel's dermatologist had no idea or updated information to hand out to his
patients. "

Mr. Stone also testified that they were not informed about the potential link to suicide:
"There was never any mention ofsuicide as a side effect. The information that
Clay brought home from the dermatologist was a brochure dated 1994 and made
no mention ofsuicide. "

As has been widely reported, the teenage son of Michigan Congressman Bart Stupak
committed suicide while taking Accutane. In a statement released October 5, 2000,
Congressman Stupak said:
"As a parent, I would have wanted to know of the risk of depression, suicide
ideation and suicide, before allowing my child to take this drug. As a legislator, I
believe that the public has a right to know of all risks associated with prescription
drugs."

Our hearing contributed to the development and implementation of a comprehensive
program to ensure that Accutane patients, and the parents of minors prescribed Accutane, are
fully informed of this concern and can make informed decisions regarding Accutane treatment.
This program includes important precautio;nary information, including an explicit informed
consent form and a patient-friendly Medication Guide.
This is why I am contacting you and asking for your assistance. If you are prescribing
Accutane to your patients, or referring patients to a dermatologist for this acne drug, please
discuss all the potential risks, monitor the patient's emotional status during and after the use of
Accutane, and otherwise comply with the elements of the above-referenced program. I am sure
you agree that if this added effort saves just one life, the time will have been well spent.
While the focus of our hearing and of this letter concerns the need for fully informed
consent regarding the potential risk of depression or suicide, the risk of birth defects and fetal
deaths are also of concern. I would also urge that you closely review the newly published
"Guide to Best Practices," and that you work closely with your patients to ensure that no unborn
child is put at risk.

Page30
Page 4 - Suicide Prevention- Fully Informed Consent With Accutane

If you would like more information, please refer to the Committee's website,
http://www.house.gov/reform under the header for transcripts. The transcript from the December
5, 2000, hearing is available under the title, "Accutane - Is this Acne Drug Treatment Linked to
Depression and Suicide?" The FDA also maintains an information page on Accutane
(http://www.fda.gov/cder/drug/infopage/accutane/default.htm) that includes the product labeling,
informed consent form and Medication Guide.
If you have any questions or would prefer a printed copy of this transcript, please contact
Professional Staff MemberS. Elizabeth Clay at 202-225-5074 (beth.clay@mail.house.gov).
Your assistance in this important matter is appreciated.
Sincerely,

/S/
Dan Burton
Chairman
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